Sernova Biotherapeutics Inc
SVA.TO
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 189.10K | 60.40K | 1.45M | 834.40K | 4.31M |
| Total Receivables | 87.50K | 192.20K | 313.30K | 257.90K | 213.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 96.30K | 108.40K | 347.70K | 336.80K | 114.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 373.00K | 361.10K | 2.11M | 1.43M | 4.64M |
|
|
|||||
| Total Current Assets | 373.00K | 361.10K | 2.11M | 1.43M | 4.64M |
| Net Property, Plant & Equipment | 12.60K | 135.20K | 534.50K | 543.30K | 598.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 159.70K | 161.80K | 162.00K | 154.70K | 160.60K |
| Total Assets | 545.30K | 658.10K | 2.80M | 2.13M | 5.40M |
|
|
|||||
| Total Accounts Payable | 12.61M | 14.22M | 13.72M | 13.72M | 12.37M |
| Total Accrued Expenses | 2.43M | 704.60K | 610.40K | 415.30K | 1.92M |
| Short-term Debt | 2.66M | 2.64M | 2.47M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 45.70K | 80.40K | 73.40K | 72.80K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 17.70M | 17.61M | 16.87M | 14.21M | 14.36M |
|
|
|||||
| Total Current Liabilities | 17.70M | 17.61M | 16.87M | 14.21M | 14.36M |
| Long-Term Debt | 744.60K | 681.50K | 583.90K | -- | -- |
| Short-term Debt | 2.66M | 2.64M | 2.47M | -- | -- |
| Capital Leases | -- | 23.50K | 296.90K | 304.20K | 336.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.44M | 18.31M | 17.76M | 14.51M | 14.70M |
|
|
|||||
| Common Stock & APIC | 100.25M | 100.46M | 100.39M | 95.41M | 98.58M |
| Retained Earnings | -118.53M | -118.43M | -115.67M | -107.82M | -107.90M |
| Treasury Stock & Other | 383.30K | 319.90K | 329.10K | 23.80K | 24.70K |
| Total Common Equity | -17.89M | -17.65M | -14.95M | -12.39M | -9.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.89M | -17.65M | -14.95M | -12.39M | -9.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.89M | -17.65M | -14.95M | -12.39M | -9.30M |
|
|
|||||